| Mislabeled Supplement Spurred Prostate Cancer: Report
FRIDAY, Jan. 18 (HealthDay News) -- A mislabeled over-the-counter product described as a dietary supplement appears to have contributed to the development of aggressive prostate cancer in two men, researchers report. "There were things on the label that were not in the product, and components in the product that were not on the label," said study author Dr. Shahrokh Shariat, chief resident in urology at the University of Texas Southwestern Medical Center. .
STILL FIGHTING: Prostate cancer survivor helps others with the disease
Larry Puccio beat prostate cancer 12 years ago, but he's still fighting the disease. Only now, he's doing it to help newly diagnosed men and survivors who need information and hope. The retired engineer joined a prostate cancer support group soon after his surgery in 1996 at Somerset Medical Center in Somerville. In 2005, he and his wife, Grace, moved from their Hillsborough home to the Holiday City South seniors development in Berkeley. Puccio decided to look for a new support group. He had an obligation to do so, he says in his quiet but measured way.
Low-Carb Diet May Slow Prostate Tumor Growth
TUESDAY, Nov. 13 (HealthDay News) -- In mice, a low-carbohydrate diet slowed prostate tumor growth, possibly because fewer carbohydrates leads to a drop in insulin production, U.S. researchers say. "This study showed that cutting carbohydrates may slow tumor growth, at least in mice. If this is ultimately confirmed in human clinical trials, it has huge implications for prostate cancer therapy through something that all of us can controls, our diets," lead researcher Dr. Stephen Freedland, a urologist at Duke University Medical Center, said in a prepared statement. Previous studies linked insulin and a related substance called insulin-like growth factor (IGF) with the growth of prostate tumors in mice. Freedland and his colleagues theorized that reducing levels of these substances might slow prostate tumor growth.
|
